---
$id: https://graph.org.ai/products/commodity/51151614
$type: Product
source: UNSPSC
code: "51151614"
title: "Homatropine hydrobromide"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Homatropine hydrobromide

**UNSPSC Code**: 51151614
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C16H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8QS6WCL55Z, chemically known as 1-alpha-h,5-alpha-h-tropan-3-alpha-ol, mandelate (ester) but generally known as homatropine, which bears US NIH Compound Identifier 3623. European Medicines Agency schedules Homatropine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02529MIG. World Health Organization schedules homatropine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule homatropine hydrobromide under HS 29399990 and SITC 54149. As of Q4 2014, HOMATROPINE HYDROBROMIDE remains the US FDA Preferred Term for this commodity. Homatropine hydrobromide bears US NLM identifiers UMLS ID C0770458 and NCI Concept Code C29093. SMILES: O(C1CC2N(C(CC2)C1)C)C(=O)C(O)C1CCCCC1.

